SARS-CoV-2 serological cross-reactivity testing in Brazilian blood donors, October-December, 2019

Affiliations

¹ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
² Department of Microbiology, Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, São Paulo, Brazil.
³ Flavivirus Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; Laboratory of Celular and Molecular Genetics, Federal University of Belo Horizonte, Belo Horizonte, Brazil.
⁴ Euro-American University Center-UNIEURO, Federal District, Brasilia, Brazil.
⁵ Faculty of Ceilândia, University of Brasilia, Federal District, Brasilia, Brazil; Center for Tropical Medicine, University of Brasilia, Federal District, Brazil.
⁶ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Center for Biotechnology (NuCel), Butantan Institute, São Paulo, São Paulo, Brazil.
⁷ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Center for Biotechnology (NuCel), Butantan Institute, São Paulo, São Paulo, Brazil. Electronic address: svetoslav.slavov@butantan.gov.br.

Comment

Victoria Simionatto Zucherato et al. J Infect. 2022 Feb.

. 2022 Feb;84(2):e1-e2.

doi: 10.1016/j.jinf.2021.12.041. Epub 2022 Jan 1.

¹ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
² Department of Microbiology, Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, São Paulo, Brazil.
³ Flavivirus Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; Laboratory of Celular and Molecular Genetics, Federal University of Belo Horizonte, Belo Horizonte, Brazil.
⁴ Euro-American University Center-UNIEURO, Federal District, Brasilia, Brazil.
⁵ Faculty of Ceilândia, University of Brasilia, Federal District, Brasilia, Brazil; Center for Tropical Medicine, University of Brasilia, Federal District, Brazil.
⁶ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Center for Biotechnology (NuCel), Butantan Institute, São Paulo, São Paulo, Brazil.
⁷ Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Center for Biotechnology (NuCel), Butantan Institute, São Paulo, São Paulo, Brazil. Electronic address: svetoslav.slavov@butantan.gov.br.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflict of interest.

SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients.
Gurgel RQ, de Sá LC, Souza DRV, Martins AF, Matos ILS, Lima AGA, Vieira SCF, Neto JMR, Cuevas LE, Borges LP. Gurgel RQ, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.11.037. Epub 2020 Dec 1. J Infect. 2021. PMID: 33271171 Free PMC article.